FDA Approves Bristol Myers Squibb’s Cobenfy: A Groundbreaking Schizophrenia Treatment
The First New Class of Antipsychotic Drugs in 70 Years Offers Hope for Millions but Faces Pricing Challenges In a ...
The First New Class of Antipsychotic Drugs in 70 Years Offers Hope for Millions but Faces Pricing Challenges In a ...
Short-Seller Accusations and Delayed Filings Trigger Market Concerns for AI Server Maker Super Micro Computer (SMCI), a prominent manufacturer of ...
Investor Expectations High for AI-Driven Growth, Despite Weakness in PCs and Smartphones Micron Technology (MU) is set to report its ...
Wedbush Upgrades Key Regional Banks as Rate Environment Shifts Favorably In a post-Federal Reserve landscape, banks are gearing up for ...
Major Changes to Business Model and Leadership Challenges as Carrier Aims for a Turnaround Southwest Airlines (LUV) is facing mounting ...
Investor Interest and Merger Talks Bring Renewed Attention to Intel's Struggles in the AI-Driven Market Intel (INTC) saw its stock ...
Server Strength Drives Upside, But Memory and Compound Semis Lag Behind Taiwan's tech supply chain showed varied performance in August, ...
Distribution Agreement with Sekorm Paves Way for B-TRAN Technology Expansion in World's Largest Semiconductor Market Ideal Power (IPWR), a leader ...
Intel's Shares Surge Amidst Rumored Acquisition Talks as Qualcomm Falls In a surprising development, Qualcomm (QCOM) has made a takeover ...
Potential End to Longstanding Partnership with Barclays as American Looks to Boost Revenue American Airlines (AAL) is negotiating with Citigroup ...
© 2024 All Rights Reserved: STOXPO.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More
In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information
Do you really wish to opt-out?